ask="1.82"
ask_size="4000"
average_daily_volume="50150"
bid="N/A"
bid_size="N/A"
book_value="0.69"
change="+0.05"
change_from_200_day_moving_average="0.02"
change_from_50_day_moving_average="-0.01"
change_from_52_week_high="-1.98"
change_From_52_week_low="0.48"
change_in_percent="+3.03%"
close="1.70"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.24"
ebitda="-6.29M"
eps_estimate_current_year="-0.16"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.48"
ex_dividend_date="N/A"
float_shares="2843000"
high="1.74"
high_52_weeks="3.68"
last_trade_date="2/27/2017"
last_trade_price="1.70"
last_trade_size="373"
last_trade_time="4:00pm"
low="1.61"
low_52_weeks="1.22"
market_capitalization="18.68M"
moving_average_200_day="1.68"
moving_average_50_day="1.71"
name="Cleveland BioLabs
Inc."
notes="N/A"
one_year_target_price="2.00"
open="1.67"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+0.90%"
percent_change_from_50_day_moving_average="-0.84%"
percent_change_from_52_week_high="-53.80%"
percent_change_from_52_week_low="+39.34%"
previous_close="1.65"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.41"
price_per_sales="5.15"
revenue="3.52M"
shares_outstanding="10987000"
short_ratio="0.62"
stock_exchange="NCM"
symbol="CBLI"
volume="36285"
weeks_range_52="1.22 - 3.68"
